Stock AnalizAstera Labs (ALAB) earnings for the quarter ended September 2026: EPS beats estimates
Astera Labs reported results for the quarter ended September 2026 on November 3, 2026. Adjusted earnings per share came in at $1.32 against the analysts’ average forecast of $1.19, a beat of 10.7%.
Revenue for the quarter was $585 million, up 153.7% from $231 million in the same quarter a year earlier.
The market’s verdict: the stock fell 2.8% on the first trading day after the report.
The last four quarters
Astera Labs has beaten the analysts’ EPS forecast in 4 of the last 4 quarters.
| Quarter | EPS | Forecast | Surprise | Revenue growth | Price reaction |
|---|---|---|---|---|---|
| Sep 2026 | $1.32 | $1.19 | +10.7% | +154% | −2.8% |
| Jun 2026 | $0.80 | $0.69 | +15.6% | +104% | −0.8% |
| Mar 2026 | $0.61 | $0.54 | +13.5% | +93% | +6.3% |
| Sep 2025 | $0.49 | $0.39 | +25.6% | +104% | −5.0% |
What comes next
Analysts expect EPS of $1.65 for the next quarter on average and $4.38 for the fiscal year ending December 31, 2026.
The average analyst price target is $344.15, 55% above the current price of $221.83.
Valuation and score
Astera Labs scores 2.0 out of 5 overall on Stock Analiz (average), trades at a trailing P/E of about 88.4, and its intrinsic value under moderate assumptions is about 22% below the current market value. Full Astera Labs analysis with 10 years of financials
Frequently asked questions
What was Astera Labs’s EPS for the quarter ended September 2026?
$1.32 adjusted per share, against an analyst consensus of $1.19.
How much revenue did Astera Labs report?
$585 million, up 153.7% year over year.
More
This report was written automatically from the published numbers within hours of the release. It is information, not investment advice.